Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Drug Alcohol Depend. 2008 Dec 5;101(1-2):34–41. doi: 10.1016/j.drugalcdep.2008.10.016

Figure 2.

Figure 2

2A. Bodyweight over the 8-week treatment period. Group differences by weight were observed, where the SR condition lost weight while the placebo (0 mg) group gained weight. 2B. Systolic blood pressure tended to change over time, and as a functioning of medication group and time. 2C. Diastolic blood pressure did not vary across group, time, or their interaction. 2D. Heart rate did not vary across group, time, or their interaction.

HHS Vulnerability Disclosure